These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37987826)

  • 1. Thalamic Foxp2 regulates output connectivity and sensory-motor impairments in a model of Huntington's Disease.
    Rodríguez-Urgellés E; Casas-Torremocha D; Sancho-Balsells A; Ballasch I; García-García E; Miquel-Rio L; Manasanch A; Del Castillo I; Chen W; Pupak A; Brito V; Tornero D; Rodríguez MJ; Bortolozzi A; Sanchez-Vives MV; Giralt A; Alberch J
    Cell Mol Life Sci; 2023 Nov; 80(12):367. PubMed ID: 37987826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postnatal Foxp2 regulates early psychiatric-like phenotypes and associated molecular alterations in the R6/1 transgenic mouse model of Huntington's disease.
    Rodríguez-Urgellés E; Rodríguez-Navarro I; Ballasch I; Del Toro D; Del Castillo I; Brito V; Alberch J; Giralt A
    Neurobiol Dis; 2022 Oct; 173():105854. PubMed ID: 36029989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of Huntington's Disease-Associated Phenotypes by the Striatum-Enriched Transcription Factor Foxp2.
    Hachigian LJ; Carmona V; Fenster RJ; Kulicke R; Heilbut A; Sittler A; Pereira de Almeida L; Mesirov JP; Gao F; Kolaczyk ED; Heiman M
    Cell Rep; 2017 Dec; 21(10):2688-2695. PubMed ID: 29212017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between subthalamic nucleus neuronal activity and electrocorticogram is altered in the R6/2 mouse model of Huntington's disease.
    Callahan JW; Abercrombie ED
    J Physiol; 2015 Aug; 593(16):3727-38. PubMed ID: 25952461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced striatal acetylcholine efflux in the R6/2 mouse model of Huntington's disease: an examination of the role of altered inhibitory and excitatory mechanisms.
    Farrar AM; Callahan JW; Abercrombie ED
    Exp Neurol; 2011 Dec; 232(2):119-25. PubMed ID: 21864528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroanatomical Visualization of the Impaired Striatal Connectivity in Huntington's Disease Mouse Model.
    Kim D; Jeon J; Cheong E; Kim DJ; Ryu H; Seo H; Kim YK
    Mol Neurobiol; 2016 May; 53(4):2276-86. PubMed ID: 25976370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Etiological Foxp2 Mutation Impairs Neuronal Gain in Layer VI Cortico-Thalamic Cells through Increased GABA
    Druart M; Groszer M; Le Magueresse C
    J Neurosci; 2020 Oct; 40(44):8543-8555. PubMed ID: 33020214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalamocortical Projections Are Significantly Impaired in the R6/2 Mouse Model of Huntington's Disease.
    Holley SM; Oikonomou KD; Swift CM; Mohan L; Matthews B; Vega O; Mkrtchyan G; Cepeda C; Levine MS
    eNeuro; 2022; 9(3):. PubMed ID: 35667848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M2 Cortex Circuitry and Sensory-Induced Behavioral Alterations in Huntington's Disease: Role of Superior Colliculus.
    Conde-Berriozabal S; García-Gilabert L; García-García E; Sitjà-Roqueta L; López-Gil X; Muñoz-Moreno E; Boutagouga Boudjadja M; Soria G; Rodríguez MJ; Alberch J; Masana M
    J Neurosci; 2023 May; 43(18):3379-3390. PubMed ID: 37001992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6/2 mouse model of Huntington's disease.
    Samadi P; Boutet A; Rymar VV; Rawal K; Maheux J; Kvann JC; Tomaszewski M; Beaubien F; Cloutier JF; Levesque D; Sadikot AF
    Genes Brain Behav; 2013 Feb; 12(1):108-24. PubMed ID: 23006318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalamostriatal degeneration contributes to dystonia and cholinergic interneuron dysfunction in a mouse model of Huntington's disease.
    Crevier-Sorbo G; Rymar VV; Crevier-Sorbo R; Sadikot AF
    Acta Neuropathol Commun; 2020 Feb; 8(1):14. PubMed ID: 32033588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered sensory experience exacerbates stable dendritic spine and synapse loss in a mouse model of Huntington's disease.
    Murmu RP; Li W; Szepesi Z; Li JY
    J Neurosci; 2015 Jan; 35(1):287-98. PubMed ID: 25568121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6/2 mouse model of Huntington's disease.
    Parievsky A; Moore C; Kamdjou T; Cepeda C; Meshul CK; Levine MS
    Neurobiol Dis; 2017 Dec; 108():29-44. PubMed ID: 28757327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice.
    Spires TL; Grote HE; Garry S; Cordery PM; Van Dellen A; Blakemore C; Hannan AJ
    Eur J Neurosci; 2004 May; 19(10):2799-807. PubMed ID: 15147313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.
    Louis Sam Titus ASC; Yusuff T; Cassar M; Thomas E; Kretzschmar D; D'Mello SR
    J Neurosci; 2017 Jul; 37(27):6575-6587. PubMed ID: 28550168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional anatomy of thalamus and basal ganglia.
    Herrero MT; Barcia C; Navarro JM
    Childs Nerv Syst; 2002 Aug; 18(8):386-404. PubMed ID: 12192499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal Direct and Indirect Pathway Output Structures Are Differentially Altered in Mouse Models of Huntington's Disease.
    Barry J; Akopian G; Cepeda C; Levine MS
    J Neurosci; 2018 May; 38(20):4678-4694. PubMed ID: 29691329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal pre-enkephalin overexpression improves Huntington's disease symptoms in the R6/2 mouse model of Huntington's disease.
    Bissonnette S; Vaillancourt M; Hébert SS; Drolet G; Samadi P
    PLoS One; 2013; 8(9):e75099. PubMed ID: 24040390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional connectivity modeling of consistent cortico-striatal degeneration in Huntington's disease.
    Dogan I; Eickhoff CR; Fox PT; Laird AR; Schulz JB; Eickhoff SB; Reetz K
    Neuroimage Clin; 2015; 7():640-52. PubMed ID: 25844318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms.
    Hebb AL; Robertson HA; Denovan-Wright EM
    Neuroscience; 2004; 123(4):967-81. PubMed ID: 14751289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.